The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Resveratrol Ameliorates Muscular Pathology in the Dystrophic mdx Mouse, a Model for Duchenne Muscular Dystrophy
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guide for the Care and Use of Laboratory Animals: Eighth Edition
(2011) · doi:10.17226/12910 · Cited by 16,199
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L.-L., et al. (2003) · Nature · doi:10.1038/nature01960 · Cited by 3,796 · cited 2×
“Resveratrol is an activator of SIRT1 (Howitz et al., 2003).”
Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1
Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., & Puigserver, P. (2005) · Nature · doi:10.1038/nature03354 · Cited by 3,160
Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase
Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D., Jones, D. R., Frye, R. A., & Mayo, M. W. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600244 · Cited by 2,750
St-Pierre, J., Drori, S., Uldry, M., Silvaggi, J. M., Rhee, J., Jäger, S., Handschin, C., Zheng, K., Lin, J., Yang, W., et al. (2006) · Cell · doi:10.1016/j.cell.2006.09.024 · Cited by 2,233
Emery, A. E. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07815-7 · Cited by 1,667
Sandri, M., Lin, J., Handschin, C., Yang, W., Arany, Z. P., Lecker, S. H., Goldberg, A. L., & Spiegelman, B. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607795103 · Cited by 974 · cited 2×
“…peroxisome proliferator-activated receptor- coactivator-1 (PGC-1 ) (Rodgers et al., 2005), which inhibits muscular atrophy induced by denervation and is involved in muscle fiber-type switching from glycolytic fast fibers to oxidative slow fibers (Sandri et al., 2006; Schuler et al., 2006).”
NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury
Hecker, L., Vittal, R., Jones, T., Jagirdar, R., Luckhardt, T. R., Horowitz, J. C., Pennathur, S., Martinez, F. J., & Thannickal, V. J. (2009) · Nature Medicine · doi:10.1038/nm.2005 · Cited by 852 · cited 4×
“Smad3 activation (Lambeth et al., 2007; Hecker et al., 2009), whereas the knockdown of Nox4 suppresses TGF- -induced -SMA and fibronectin expression in cardiac and lung fibroblasts (Cucoranu et al.”
InfluentialCucoranu, I., Clempus, R., Dikalova, A., Phelan, P. J., Ariyan, S., Dikalov, S., & Sorescu, D. (2005) · Circulation Research · doi:10.1161/01.res.0000187457.24338.3d · Cited by 786
NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart
Kuroda, J., Ago, T., Matsushima, S., Zhai, P., Schneider, M. D., & Sadoshima, J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002178107 · Cited by 772
Cited by
Regulation of FOXOs and p53 by SIRT1 Modulators under Oxidative Stress
Hori, Y. S., Kuno, A., Hosoda, R., & Horio, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073875 · Cited by 358
Self-citationOf mice and men: the benefits of caloric restriction, exercise, and mimetics
Mercken, E. M., Carboneau, B. A., Krzysik-Walker, S. M., & de Cabo, R. (2012) · Ageing Research Reviews · doi:10.1016/j.arr.2011.11.005 · Cited by 318
Lieber, R. L., & Ward, S. R. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00173.2013 · Cited by 307
Sirt1 Inhibits Oxidative Stress in Vascular Endothelial Cells
Zhang, W., Huang, Q., Zeng, Z., Wu, J., Zhang, Y., & Chen, Z. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/7543973 · Cited by 272
Zarzuelo, M. J., López-Sepúlveda, R., Sánchez, M., Romero, M., Gómez-Guzmán, M., Ungvary, Z., Pérez-Vizcaíno, F., Jiménez, R., & Duarte, J. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.02.015 · Cited by 202
Turn up the power - pharmacological activation of mitochondrial biogenesis in mouse models
Komen, J. C., & Thorburn, D. R. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12413 · Cited by 149
“…mimicked the effect observed by PGC-1α overexpression including reduction of muscle tissue loss, changes in fibre-type composition and reduction of oxidative damage in 1826 British Journal of Pharmacology (2014) 171 1818–1836 skeletal muscle of mdx mice (Handschin et al., 2007; Hori et al., 2011).”
BackgroundMethodChalkiadaki, A., Igarashi, M., Nasamu, A. S., Knezevic, J., & Guarente, L. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004490 · Cited by 126
Kuno, A., Hosoda, R., Sebori, R., Hayashi, T., Sakuragi, H., Tanabe, M., & Horio, Y. (2018) · Scientific Reports · doi:10.1038/s41598-018-33930-w · Cited by 88
Self-citationPolyphenols and Their Potential Role in Preventing Skeletal Muscle Atrophy
Salucci, S., & Falcieri, E. (2020) · Nutrition Research · doi:10.1016/j.nutres.2019.11.004 · Cited by 83
SIRT1 signaling as potential modulator of skeletal muscle diseases
Tonkin, J., Villarroya, F., Puri, P. L., & Vinciguerra, M. (2012) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2012.02.010 · Cited by 60
Sun, L.-J., Sun, Y.-N., Chen, S.-J., Liu, S., & Jiang, G.-R. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.04.022 · Cited by 35
Asami, Y., Aizawa, M., Kinoshita, M., Ishikawa, J., & Sakuma, K. (2018) · International Journal of Medical Sciences · doi:10.7150/ijms.22723 · Cited by 33
Giovarelli, M., Zecchini, S., Casati, S. R., Lociuro, L., Gjana, O., Mollica, L., Pisanu, E., Mbissam, H. D., Cappellari, O., De Santis, C., et al. (2025) · Cell Death & Disease · doi:10.1038/s41419-025-07595-z · Cited by 12
Metadata
- Authors
- Hori, Y. S., Kuno, A., Hosoda, R., Tanno, M., Miura, T., Shimamoto, K., & Horio, Y.
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 2011-09
- Volume
- 338
- Issue
- 3
- Pages
- 784-794
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W2115987361
- Cited by
- 164
- References
- 12
- FWCI
- 4.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.